Association of alterations in homologous recombination repair genes with survival and chemotherapy sensitivity in patients with high-grade serous ovarian cancer

被引：0
|
作者：
Khan, Sofia [1 ,2 ]
Nevanlinna, Heli [1 ,2 ]
机构：
[1] Univ Helsinki, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Helsinki, Finland
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3107
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3107
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CLINICAL CHARACTERISTICS AND GENOMIC BIOMARKERS OF THE HOMOLOGOUS RECOMBINATION DEFICIENCY PHENOTYPE IN HIGH-GRADE SEROUS OVARIAN CANCER
    Vanderstichele, A.
    Nulens, K.
    Busschaert, P.
    Van Nieuwenhuysen, E.
    Han, S.
    Concin, N.
    Neven, P.
    Berns, E.
    Braicu, I.
    Castillo-Tong, A. Cacsire
    Mahner, S.
    Sehouli, J.
    Zeillinger, R.
    Smeets, D.
    Lambrechts, D.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1818 - 1818
  • [22] Acquired chemotherapy resistance in high-grade serous ovarian cancer patients.
    Christie, Elizabeth L.
    Beach, Jessica
    Etemadmoghadam, Dariush
    Garsed, Dale
    Patch, Ann-Marie
    Fereday, Sian
    Pattnaik, Swetansu
    Brady, Samuel
    Bild, Andrea
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 20 - 20
  • [23] T cell exhaustion correlates with homologous recombination and determines survival in high grade serous ovarian cancer
    Del, Mathilde
    Salvioni, Anna
    Bataillon, Guillaume
    Michelas, Marie
    Segier, Bertille
    Betrian, Sarah
    Ferron, Gwenael
    Ayyoub, Maha
    Martinez, Alejandra
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A506 - A506
  • [24] Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma
    Pitiyarachchi, Omali
    Lee, Yeh Chen
    Sim, Hao-Wen
    Srirangan, Sivatharsny
    Mapagu, Cristina
    Kirk, Judy
    Harnett, Paul R.
    Balleine, Rosemary L.
    Bowtell, David D. L.
    Samimi, Goli
    Brand, Alison H.
    Marsh, Deborah J.
    Beale, Philip
    Anderson, Lyndal
    Bouantoun, Natalie
    Provan, Pamela
    Ramus, Susan J.
    DeFazio, Anna
    Friedlander, Michael
    TRANSLATIONAL ONCOLOGY, 2023, 31
  • [25] Focal adhesion kinase inhibitors as maintenance therapy in a homologous recombination repair proficient high-grade serous ovarian cancer murine model
    Hill, Breana
    Bondre, Ioana
    Tahon, Elise
    Soylu, Halime Meryem
    Chen, Xiao Lei
    Ojalill, Marjaana
    Zhang, Joanna
    Hom-Tedla, Marianne
    Wilson, Elise
    Saenz, Cheryl
    Plaxe, Steven
    Eskander, Ramez
    Binder, Pratibha
    McHale, Michael
    Schlaepfer, David
    Stupack, Dwayne
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S93 - S94
  • [26] Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
    Feng, Zheng
    Shao, Di
    Cai, Yuhang
    Bi, Rui
    Ju, Xingzhu
    Chen, Dongju
    Song, Chengcheng
    Chen, Xiaojun
    Li, Jin
    An, Na
    Li, Yunjin
    Zhou, Qing
    Xiu, Zhihui
    Zhu, Shida
    Wu, Xiaohua
    Wen, Hao
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [27] Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
    Zheng Feng
    Di Shao
    Yuhang Cai
    Rui Bi
    Xingzhu Ju
    Dongju Chen
    Chengcheng Song
    Xiaojun Chen
    Jin Li
    Na An
    Yunjin Li
    Qing Zhou
    Zhihui Xiu
    Shida Zhu
    Xiaohua Wu
    Hao Wen
    Journal of Ovarian Research, 16
  • [28] Homologous recombination deficiency test validation in patients with high-grade advanced ovarian cancer
    Rodrigues, Angelica Nogueira
    Souto, Andreza Karine de Barros Almeida
    de Andrade, Diocesio Alves Pinto
    Gomes, Larissa Mueller
    Koide, Sandra Satie
    Silva, Renata de Godoy
    de Souza, Bruno Batista
    Massaro, Juliana Doblas
    de Melo, Andreia Cristina
    Borges, Andrea Morais
    Giro, Camila
    de Andrade, Carlos Augusto Vasconcelos
    da Costa, Cesar Martins
    Gimenes, Daniel Luiz
    de Mello, Eduardo Caminha Bandeira
    de Oliveira, Fernanda Cesar
    Lima, Frederico Mueller de Toledo
    Lopes, Gabriel Lima
    Bretas, Gustavo de Oliveira
    Jacob, Gustavo Guerra
    da Costa e Silva, Herika Lucia
    Notaro, Juliana Ferrari
    Alves, Lara Ladislau
    Moitinho, Marcos Veloso
    da Silva, Mirian Cristina
    Abramoff, Roberto
    Rauber, Thais Amaral da Cunha
    Dienstmann, Rodrigo
    Koyama, Fernanda Christtanini
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2025, 12
  • [29] CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors
    Xue Lu
    Yaowu He
    Rebecca L. Johnston
    Devathri Nanayakarra
    Sivanandhini Sankarasubramanian
    J. Alejandro Lopez
    Michael Friedlander
    Murugan Kalimutho
    John D. Hooper
    Prahlad V. Raninga
    Kum Kum Khanna
    Journal of Experimental & Clinical Cancer Research, 41
  • [30] CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors
    Lu, Xue
    He, Yaowu
    Johnston, Rebecca L.
    Nanayakarra, Devathri
    Sankarasubramanian, Sivanandhini
    Lopez, J. Alejandro
    Friedlander, Michael
    Kalimutho, Murugan
    Hooper, John D.
    Raninga, Prahlad V.
    Khanna, Kum Kum
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
12345